You are here: Industry Insights > AbbVie

News List

AbbVie Submits Regulatory Applications to FDA, EMA for Psoriatic Arthritis Treatment americanpharmaceuticalreview
June 15, 2020
AbbVie has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for RINVOQ™ (upadacitinib; 15 mg, once daily), a selective and reversible JAK inhibitor ...
AbbVie inks $750m cancer therapeutics deal with Genmab pharmaceutical-technology
June 15, 2020
AbbVie has entered a collaboration agreement with biotechnology company Genmab to develop and commercialise antibody therapeutics for cancer.
Abbvie, Genmab Enter $750M Antibody Alliance contractpharma
June 11, 2020
To jointly develop and commercialize three of Genmab's early-stage investigational bispecific antibody product candidates.
AbbVie and partners to develop monoclonal antibody against Covid-19 pharmaceutical-technology
June 09, 2020
AbbVie has partnered with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a monoclonal antibody therapeutic for the prevention and treatment of Covid-19.
AbbVie files Rinvoq for psoriatic arthritis pharmatimes
June 04, 2020
AbbVie is seeking to expand the scope of Rinvoq (upadacitinib) in the US and Europe to include the treatment of adults with active psoriatic arthritis.
AbbVie partners with Jacobio Pharmaceuticals for cancer drugs pharmaceutical-technology
June 03, 2020
AbbVie has collaborated with Jacobio Pharmaceuticals for the development and commercialisation of SHP2 inhibitors that act on an important node in cancer and immune cells.
AbbVie completes acquisition of Allergan expresspharma
May 14, 2020
The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in immunology.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.
FTC Clears AbbVie’s Acquisition of Allergan contractpharma
May 07, 2020
Only one Allergan director will join the AbbVie board after close.
US regulators permit AbbVie/Allergan merger pharmatimes
May 06, 2020
AbbVie's plans to acquire Allergan have been cleared by the US Federal Trade Commission (FTC).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page